diabetestalk.net

Effect Of Probiotics On Glucose And Lipid Metabolism In Type 2 Diabetes Mellitus: A Meta-Analysis Of 12 Randomized Controlled Trials

Effect of Probiotics on Glucose and Lipid Metabolism in Type 2 Diabetes Mellitus: A Meta-Analysis of 12 Randomized Controlled Trials

Effect of Probiotics on Glucose and Lipid Metabolism in Type 2 Diabetes Mellitus: A Meta-Analysis of 12 Randomized Controlled Trials


Effect of Probiotics on Glucose and Lipid Metabolism in Type 2 Diabetes Mellitus: A Meta-Analysis of 12 Randomized Controlled Trials
Kecheng Yao ,1,A,B,C,D,F,* Linghai Zeng ,1,A,B,C,D,* Qian He ,1,B,C,F,* Wei Wang ,2,C,E,F Jiao Lei ,3,B,D and Xiulan Zou 1,B,E
1Department of Gerontology, Renmin Hospital of Three Gorges University and The First Peoples Hospital of Yichang, Yichang, Hubei, P.R. China
1Department of Gerontology, Renmin Hospital of Three Gorges University and The First Peoples Hospital of Yichang, Yichang, Hubei, P.R. China
1Department of Gerontology, Renmin Hospital of Three Gorges University and The First Peoples Hospital of Yichang, Yichang, Hubei, P.R. China
2Department of Endocrinology, Renmin Hospital of Three Gorges University and The First Peoples Hospital of Yichang, Yichang, Hubei, P.R. China
3Department of General Surgery, Renmin Hospital of Three Gorges University and The First Peoples Hospital of Yichang, Yichang, Hubei, P.R. China
1Department of Gerontology, Renmin Hospital of Three Gorges University and The First Peoples Hospital of Yichang, Yichang, Hubei, P.R. China
1Department of Gerontology, Renmin Hospital of Three Gorges University and The First Peoples Hospital of Yichang, Yichang, Hubei, P.R. China
2Department of Endocrinology, Renmin Hospital of Three Gorges University and The First Peoples Hospital of Yichang, Yichang, Hubei, P.R. China
3Department of General Surgery, Renmin Hospital of Three Gorges University and The First Peoples Hospital of Yichang, Yichang, Hubei, P.R. China
Corresponding Author: Xiulan Zou, e-mail: moc. Continue reading

Rate this article
Total 1 ratings
THINGS YOU NEED TO KNOW: Local boy advocates for more Type 1 diabetes research

THINGS YOU NEED TO KNOW: Local boy advocates for more Type 1 diabetes research


THINGS YOU NEED TO KNOW: Local boy advocates for more Type 1 diabetes research
Today is National Hot Dog Day. You either like hot dogs or you dont. If you dont, you can ignore the day, but if you do, head over to Pilot Flying J, 17047 Zachary Ave., for a free hot dog. The promotion lasts for a week from July 19 through July 26. This offer can be redeemed by displaying the online coupon available at NationalHotDogDay.PilotFlyingJ.com or at Pilot Flying Js Facebook page at the time of purchase in-store.
To paint: Have a colorful Paint Night at 1933, 7900 Downing Ave., from 7 to 10 p.m. The teacher leads the class through the steps to create a palm tree sunset acrylic masterpiece. Tickets are $45. The cost covers the painting supplies. Head to paintnite.com for tickets.
Rush Air Sports is not just for kids. At the Jumpin & Drinkin event on Wednesday, those 21 and over get an hour to bounce then cool down next door with a beer and chicken wings at Temblor.
To do: If you feel like playing and drinking, the Jumpin and Drinkin event is perfect for you. Rush Air Sports and Temblor Brewing are teaming up for the 21-and-older event, with an hour of jumping at the indoor trampoline park starting at 7:30 p.m. followed by a pint of beer and six chicken wings at Temblor from 8:30 to 9:30 p.m. Tickets are $20 and available at Rush Air Sports. Both businesses are at 3200 Buck Owens Blvd. Call Rush Air Sports at 864-7874 or Temblor at 489-4855 for more information.
To watch: Maya Cinemas, 1000 California Ave., is showing Hotel Transylvania as part of the theaters Summer Kids Film Fes Continue reading

New Skin Patch Monitors Glucose and Delivers Diabetes Drugs

New Skin Patch Monitors Glucose and Delivers Diabetes Drugs

People with diabetes need to closely monitor their blood glucose levels multiple times every day, usually using a device that pricks their finger for a blood test to assess whether they need insulin shots or other drugs. Since blood collection and shots can be painful, not all patients do it as regularly as they need to—which can lead to dangerous fluctuations in their blood glucose levels.
Researchers have worked for years on methods to improve and even automate blood glucose monitoring and insulin/drug delivery. For example, insulin pumps make drug delivery easier, and recently designed artificial pancreas systems offer closed-loop monitoring and drug delivery. Now, researchers in Korea have just developed a wearable, and potentially disposable, glucose monitoring and drug-delivery system that uses sweat, not blood, to determine glucose levels.
The results, published today in Science Advances, suggest it’s a major upgrade. There are several differences between the artificial pancreas and the sweat-based monitoring system, according to lead author Hyunjae Lee, of Seoul National University in the Republic of Korea. While both devices can check blood glucose in real time and deliver necessary drugs, the artificial pancreas’s drug-delivery needles are permanently embedded subcutaneously, and the device itself is made of rigid plastic, which "might cause discomfort," Lee tells mental_floss.
The sweat-based system, on the other hand, is transfer-printed onto a thin silicone skin patch. It’s made of flexible and stretchable electronics, a series of stretchable graphene s Continue reading

Managing Diabetes on Little Sleep: How to Keep Blood Sugar Controlled | Everyday Health

Managing Diabetes on Little Sleep: How to Keep Blood Sugar Controlled | Everyday Health


Sometimes its impossible to get at least seven hours of sleep per night, but insufficient zs dont have to derail your health goals when living with diabetes.
A growing body of research suggests that getting enough quality sleep is one of the most important factors in our mental and physical health. In fact, you need sleep to live and yet so many people come up short, be it due to stress, lack of time, one of many sleep disorders, or other factors.
So how much sleep do you need for optimal health? The National Sleep Foundation recommends that adults ages 18 to 64 get seven to nine hours, while older adults ages 65 and older get seven to eight hours of snooze time. But one-third of Americans dont get enough sleep, according to a study from the Centers for Disease Control and Prevention (CDC) in February 2016 .
Because insufficient sleep is so widespread, the CDC has declared it a public health problem , pointing to a lack of sleeps link to weight gain, heart disease, depression, and more.
For people with type 2 diabetes or at risk for the disease , the consequences can be particularly dangerous.
The Relationship Between Sleep and Diabetes Risk
For one, shorting yourself on shut-eye raises your risk of type 2 diabetes. Compared with sleeping the minimum recommended seven hours, your odds for developing the disease rise by 9 percent for every hour of shut-eye that you cut, suggests a review published in March 2015 in Diabetes Care .
Past research, the review points out, has shown that a lack of sleep may prompt the body to produce inadequate insulin and boost blood su Continue reading

Teens with Type 1 + Depression

Teens with Type 1 + Depression


You may already know that depression and diabetes are related, and it turns out that teenagers with Type 1 can be especially susceptible to depression. According to SAMSAs National Survey on Drug Use and Health , more adolescents between the ages of 12 and 17 with Type 1 or Type 2 diabetes experienced a major depressive episode (MDE) within the past year than their peers without diabetes. Experiencing MDEs is different from experiencing diabetes distress , and its important to distinguish between the two in order to best address mental health issues in teens with diabetes.
[The research] is concerning because depression can affect not just your mood and your energy level, but also how you take care of yourself. That includes taking care of diabetes, says Molly L. Tanenbaum, Ph.D. Molly is an instructor in the Department of Pediatrics at the Stanford University School of Medicine. It can be difficult to identify the reasons behind symptoms of depression. If we point to diabetes first, we miss an opportunity to learn whats going on and to offer support.
Symptoms of depression can be identified via a PHQ-9 screening questionnaire and can include:
These symptoms last for two weeks or more and vary from teenager to teenager. If you think youre experiencing symptoms of depression or thoughts of hurting yourself, let your healthcare team know right away.
Two people could get the same score on a questionnaire, and one could be feeling really distressed and discouraged about diabetes, and the other could be feeling down and struggling with school but with diabetes not really b Continue reading

No more pages to load

Popular Articles

  • Finnish Researchers Set to Start Type 1 Diabetes Vaccine Trials?
    Finnish Researchers Set to Start Type 1 Diabetes Vaccine Trials?

    In July 2017, it was announced that Finnish researchers would begin human trials of a Type 1 diabetes vaccine in 2018. On 19 July 2017, the Finnish news web site Yle reported that a group of Finnish researchers had developed a vaccine for Type 1 diabetes, and that human trials were set to begin in 2018: A vaccine for type 1 diabetes developed by Finnish researchers will be tested on mainly Finnish ...

  • A Vaccine For Type 1 Diabetes Begins Human Trials in 2018
    A Vaccine For Type 1 Diabetes Begins Human Trials in 2018

    A prototype vaccine, decades in the making, that could prevent type 1 diabetes in children is ready to start clinical trials in 2018. It's not a cure, and it won't eliminate the disease altogether, but the vaccine is expected to provide immunity against a virus that has been found to trigger the body's defences into attacking itself, potentially reducing the number of new diabetes cases each year. ...

  • A Vaccine For Type 1 Diabetes Begins Human Trials in 2018
    A Vaccine For Type 1 Diabetes Begins Human Trials in 2018

    A prototype vaccine, decades in the making, that could prevent type 1 diabetes in children is ready to start clinical trials in 2018. It's not a cure, and it won't eliminate the disease altogether, but the vaccine is expected to provide immunity against a virus that has been found to trigger the body's defences into attacking itself, potentially reducing the number of new diabetes cases each year. ...

  • Blood Pressure Drug Verapamil May Reverse Type 1 Diabetes; Human Trials To Begin Next Year
    Blood Pressure Drug Verapamil May Reverse Type 1 Diabetes; Human Trials To Begin Next Year

    It’s really expensive for pharmaceutical companies to develop a single new drug. According to Forbes, it can cost anywhere from $1.3 billion to $5 billion. Because of this, it makes drug companies very happy when they discover one of their drugs can be used for other health conditions — after all, more people treated means more money in executive’s pockets. Well, a case like this was just di ...

  • Type 1 diabetes vaccine moving to human trials in Finland
    Type 1 diabetes vaccine moving to human trials in Finland

    It has long been hypothesized that viral infections play a significant role in the development of type 1 diabetes. Researchers in Finland have been investigating this connection for over 25 years and now believe they have targeted the particular virus group that can trigger the disease. After developing a prototype vaccine the team is now moving to human clinical trials in 2018. Though not as comm ...

  • Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes
    Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes

    , Volume 60, Issue9 , pp 16201629 | Cite as Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes Metformin is the most-prescribed oral medication to lower blood glucose worldwide. Yet previous systematic reviews have raised doubts about its effectiveness in reducing risk of cardiovascular disease, the most costly complication of ...

  • ‘Type 3 diabetes’: New links emerge between poor glucose metabolism and Alzheimer’s disease
    ‘Type 3 diabetes’: New links emerge between poor glucose metabolism and Alzheimer’s disease

    Alzheimer’s disease is often broadly referred to as “Type 3 diabetes,” because it’s thought that glucose processing goes haywire in the neurodegenerative disease, just as it does in diabetes. A new National Institutes of Health study adds some credence to that theory, finding that glitches in the way the brain breaks down glucose — a process called glycolysis — seem to correspond with ...

  • The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus
    The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus

    The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus Westman et al; licensee BioMed Central Ltd.2008 Dietary carbohydrate is the major determinant of postprandial glucose levels, and several clinical studies have shown that low-carbohydrate diets improve glycemic control. In this study, we tested the hypothesis that ...

  • Postprandial Blood Glucose Is a Stronger Predictor of Cardiovascular Events Than Fasting Blood Glucose in Type 2 Diabetes Mellitus, Particularly in Women: Lessons from the San Luigi Gonzaga Diabetes Study
    Postprandial Blood Glucose Is a Stronger Predictor of Cardiovascular Events Than Fasting Blood Glucose in Type 2 Diabetes Mellitus, Particularly in Women: Lessons from the San Luigi Gonzaga Diabetes Study

    Postprandial Blood Glucose Is a Stronger Predictor of Cardiovascular Events Than Fasting Blood Glucose in Type 2 Diabetes Mellitus, Particularly in Women: Lessons from the San Luigi Gonzaga Diabetes Study Diabetes Unit, Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital (F.C., M.Tra., K.B., E.F., M.C., G.A., M.Tro.), 10043 Orbassano, Turin, Italy Se ...

Related Articles